Bruno Giraudeau

发表

Sample size calculation for meta‐epidemiological studies

Julian P T Higgins, Bruno Giraudeau, Elsa Tavernier, 2016, Statistics in medicine.

Inverse probability weighting to control confounding in an illness‐death model for interval‐censored data

Raphaël Porcher, Etienne Dantan, Yohann Foucher, 2018, Statistics in medicine.

Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?

Bruno Giraudeau, Elsa Tavernier, Ludovic Trinquart, 2016, PloS one.

Performance of principal scores to estimate the marginal compliers causal effect of an intervention

Isabelle Boutron, Raphaël Porcher, Gabriel Baron, 2016, Statistics in medicine.

Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience

Sarah Zohar, Bruno Giraudeau, Elsa Tavernier, 2020, Statistics in biopharmaceutical research.

Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis.

Isabelle Boutron, Philippe Ravaud, Bruno Giraudeau, 2003, JAMA.

Role of contrast-enhanced ultrasound in the blinded assessment of focal liver lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial

François Tranquart, Michel Claudon, Christophe Aubé, 2008 .

Peer Review of Grant Applications: A Simple Method to Identify Proposals with Discordant Reviews

Bruno Giraudeau, Clémence Leyrat, Amélie Le Gouge, 2011, PloS one.

Reporting of sample size calculation in randomised controlled trials: review

Philippe Ravaud, Gabriel Baron, Bruno Giraudeau, 2009, BMJ : British Medical Journal.

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial

Douglas G Altman, Isabelle Boutron, Philippe Ravaud, 2015, BMC Medicine.

Anisotropy changes in post-menopausal osteoporosis: characterization by a new index applied to trabecular bone radiographic images

Rachid Harba, Gérald Lemineur, Christine Chappard, 2005, Osteoporosis International.

Diet, Cancer, and the Lipidome

Bruno Giraudeau, B. Giraudeau, C. Couet, 2006, Cancer Epidemiology Biomarkers & Prevention.

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

Isabelle Boutron, Philippe Ravaud, Bruno Giraudeau, 2004, Journal of clinical epidemiology.

International Physical Activity Questionnaire-Long--French Version

Pierre Lecomte, Jean-Michel Oppert, Bruno Giraudeau, 2015 .

Ankle-brachial index and peripheral arterial disease.

Bruno Giraudeau, Emilie Vierron, Jean-Michel Halimi, 2010, The New England journal of medicine.

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study.

Sylvie Chevret, Philippe Ravaud, Geneviève Chêne, 2011, Contemporary clinical trials.

Reproducibility and validity of the French version of the long international physical activity questionnaire in patients with type 2 diabetes.

Pierre Lecomte, Jean-Michel Oppert, Bruno Giraudeau, 2011, Journal of physical activity & health.

Quality of reporting of noninferiority and equivalence randomized trials.

Philippe Ravaud, Gabriel Baron, Bruno Giraudeau, 2006, JAMA.

Planning a cluster randomized trial with unequal cluster sizes: practical issues involving continuous outcomes

Philippe Ravaud, Bruno Giraudeau, P. Ravaud, 2006, BMC medical research methodology.

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.

David Moher, Isabelle Boutron, Philippe Ravaud, 2005, Journal of clinical epidemiology.

Preoperative measurement of thickness of cutaneous melanoma using high-resolution 20 MHz ultrasound imaging: A monocenter prospective study and systematic review of the literature.

Bruno Giraudeau, B. Giraudeau, L. Vaillant, 2009, Ultrasound in medicine & biology.